Advanced search
Publication Cover
Current Medical Research and Opinion Volume 34, 2018 - Issue 1
Submit an article Journal homepage
513
Views
14
CrossRef citations to date
0
Altmetric
Musculoskeletal

Adherence, persistence, and discontinuation among Hispanic and African American patients with multiple sclerosis treated with fingolimod or glatiramer acetate

Mitzi J. WilliamsMultiple Sclerosis Center of Atlanta, Atlanta, GA, USA;
,
Kristen JohnsonNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA;
,
Helen M. TrenzOptum, Eden Prairie, MN, USA; Correspondence[email protected]
,
Stephanie KorrerOptum, Eden Prairie, MN, USA;
,
Rachel HalpernOptum, Eden Prairie, MN, USA;
,
Yujin ParkUniversity of Maryland School of Pharmacy, Baltimore, MD, USA
&
Vivian HerreraNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA;
show all
Pages 107-115 | Received 05 Apr 2017, Accepted 22 Aug 2017, Published online: 03 Oct 2017

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jagadeswara R Earla, George J Hutton, J Douglas Thornton, Hua Chen, Michael L Johnson & Rajender R Aparasu. (2020) Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis. Patient Preference and Adherence 14, pages 2187-2199.
Read now
Karen Schreiber, Matthias Kant, Claudia Pfleger, Henrik Boye Jensen, Ole Oesterberg, Anne Rieper Hald, Frederik K Nielsen & Sune Rubak. (2018) High treatment adherence, satisfaction, motivation, and health-related quality of life with fingolimod in patients with relapsing-remitting multiple sclerosis – results from a 24-month, multicenter, open-label Danish study. Patient Preference and Adherence 12, pages 1139-1150.
Read now

Articles from other publishers (12)

Jagadeswara Rao Earla, Jieni Li, George J. Hutton, John P. Bentley & Rajender R. Aparasu. (2024) Association of oral disease-modifying agents and their adherence trajectories with annual relapses in multiple sclerosis. Multiple Sclerosis and Related Disorders 85, pages 105539.
Crossref
Caroline Kelley Geiger, Daniel Sheinson, Tu My To, David Jones & Nicole Gidaya Bonine. (2023) Treatment Patterns by Race and Ethnicity in Newly Diagnosed Persons with Multiple Sclerosis. Drugs - Real World Outcomes 10:4, pages 565-575.
Crossref
Jagadeswara Rao Earla, Jieni Li, George J. Hutton, Michael L. Johnson & Rajender R. Aparasu. (2023) Comparative adherence trajectories of oral disease‐modifying agents in multiple sclerosis. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 43:6, pages 473-484.
Crossref
Lilyana Amezcua, Victor M. Rivera, Teresa Corona Vazquez, Lourdes Baezconde-Garbanati & Annette Langer-Gould. (2021) Health Disparities, Inequities, and Social Determinants of Health in Multiple Sclerosis and Related Disorders in the US. JAMA Neurology 78:12, pages 1515.
Crossref
Carlos A Pérez & John A Lincoln. (2021) Racial and ethnic disparities in treatment response and tolerability in multiple sclerosis: A comparative study. Multiple Sclerosis and Related Disorders 56, pages 103248.
Crossref
Joshua MardanMohammad Akhtar HussainMichelle AllanLisa B Grech. (2021) Objective medication adherence and persistence in people with multiple sclerosis: a systematic review, meta-analysis, and meta-regression. Journal of Managed Care & Specialty Pharmacy 27:9, pages 1273-1295.
Crossref
Hamza Coban, Sarah Germaine, Ian Dimaandal, Nicholas Haberli, Charanpreet Padam, Marina A. Creed & Jaime Imitola. (2021) Real-world experience of ocrelizumab initiation in a diverse multiple sclerosis population. Multiple Sclerosis and Related Disorders 53, pages 103021.
Crossref
Adam BurkhardJoshua ToliverKaren Rascati. (2021) Association between multiple sclerosis disease severity and adherence to disease-modifying therapies. Journal of Managed Care & Specialty Pharmacy 27:7, pages 915-923.
Crossref
Jacqueline A. Nicholas, Natalie C. Edwards, Roger A. Edwards, Anna Dellarole, Megan Grosso & Amy L. Phillips. (2020) Real-world adherence to, and persistence with, once- and twice-daily oral disease-modifying drugs in patients with multiple sclerosis: a systematic review and meta-analysis. BMC Neurology 20:1.
Crossref
Mitzi J. Williams, Lilyana Amezcua, Annette Okai, Darin T. Okuda, Stanley Cohan, Ray Su, Becky Parks, Jason P. Mendoza, James B. Lewin & Cynthia C. Jones. (2020) Real-World Safety and Effectiveness of Dimethyl Fumarate in Black or African American Patients with Multiple Sclerosis: 3-Year Results from ESTEEM. Neurology and Therapy 9:2, pages 483-493.
Crossref
Almudena Buesa-Estelléz, Roberto Cano-de-la-Cuerda, Rosa María Ortiz-Gutiérrez & Domingo Palacios-Ceña. (2019) The impact of pharmacological treatment on patients with multiple sclerosis. Disability and Health Journal 12:4, pages 615-621.
Crossref
Alexis de Roquemaurel, Paola Galli, Anne Landais, Samuel Avendano & Philippe Cabre. (2019) Fingolimod for the treatment of multiple sclerosis in French West Indies, a real-world study in patients from African ancestry. Journal of the Neurological Sciences 402, pages 180-187.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.